Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives
Native IGF-1 exists as an FDA-approved human drug: recombinant human IGF-1, marketed as mecasermin (brand name Increlex), is approved for the treatment of growth failure in children with severe primary IGF-1 deficiency and in patients who have developed neutralizing antibodies to growth hormone
Electrolytes can be helpful for some GLP-1 users, especially during low-intake days, hot weather, workouts, vomiting, diarrhea, headaches, dizziness, or dose-increase weeks
The providers who work through telehealth platforms are accustomed to ongoing communication with their patients and welcome your engagement
Impurities and degradation byproducts from poor synthesis or poor storage
He adds that the shame and social stigma around weight have a lot of impact on this, despite many people just being genetically unfortunate to have higher body weights